PK Consultancy provides clinical pharmacology, pharmacokinetic, and PK/PD modeling and simulation expertise. We will work in an integrated manner with your team. Company Mission: Scientific excellence and skilled technical capabilities, with a focus on technical expertise being current and attention to detail. Provide high quality and consistent contracting services Provide clinical pharmacology services to all clients in need in a timely manner Further advance drug development Capabilities: Clinical and non-clinical NCA – Pharmacokinetic analysis plan (PKAP), PK analysis, TLG generation, report writing Compartmental and population PK and PKPD – MAP, Analysis dataset generation, analysis, progress development meetings, and report Graphical data analysis – can be used during clinical and non-clinical drug development in order to better understand data and drive program decision making Prediction of first in human PK using allometric scaling Study types: FIH dose prediction Dose escalation (with rapid turnaround) Single Ascending Dose (SAD) Multiple Ascending Doses (MAD) Food Effect (FE) Bioavailability/Bioequivalence (BA/BE) Drug-Drug Interaction (DDI) Special Population (hepatic and renal impairment) Phase 3 studies Post-marketing support